SCHEMBL6869319

SCHEMBL6869319

COc1cccc(CC(=O)NC2CCC(Nc3nccc(N(C)C)n3)CC2)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 3/20 0.55
SIGMAR1 Q99720 2/20 0.52
CYP3A4 P08684 8/20 0.51
POLB P06746 1/20 0.49
AURKB Q96GD4 2/20 0.47
CNR1 P21554 1/20 0.47
KCNH2 Q12809 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CCNA2 P20248 1/20 0.43
CDK2 P24941 1/20 0.43
CCNA1 P78396 1/20 0.43
ROCK1 Q13464 5/20 0.42
PRKACA P17612 2/20 0.42
AURKA O14965 1/20 0.42
ADRA2A P08913 1/20 0.42
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6869316 1.00 MCHR1 (0.55) MCHR1SIGMAR1CYP3A4POLBAURKB
SCHEMBL6876586 0.91 AURKB (0.54) MCHR1SIGMAR1CYP3A4AURKBCNR1
SCHEMBL6876573 0.91 AURKB (0.54) MCHR1SIGMAR1CYP3A4AURKBCNR1
SCHEMBL6868818 0.91 CCR8 (0.51) MCHR1SIGMAR1CYP3A4AURKBCNR1
SCHEMBL6868814 0.91 CCR8 (0.51) MCHR1SIGMAR1CYP3A4AURKBCNR1
SCHEMBL6455517 0.90 CYP3A4 (0.47) MCHR1SIGMAR1CYP3A4POLBAURKB
SCHEMBL6455512 0.90 CYP3A4 (0.47) MCHR1SIGMAR1CYP3A4POLBAURKB
SCHEMBL6460756 0.89 SMN1; SMN2 (0.60) MCHR1CYP3A4POLBAURKBCNR1
SCHEMBL6460771 0.89 SMN1; SMN2 (0.60) MCHR1CYP3A4POLBAURKBCNR1
SCHEMBL6869412 0.88 EPHX2 (0.55) MCHR1SIGMAR1CYP3A4POLBAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed